Escalating COPD Care: From Flares to Long-Term Control
About this episode
This episode features Drs. Ravi Kalhan and Meilan Han discussing the latest updates in COPD care, focusing on exacerbations and treatment strategies.
Guest: Ravi Kalhan, MD Guest: MeiLan K. Han, MD, MS For patients with chronic obstructive pulmonary disease (COPD), exacerbations are early indicators of disease progression—not just isolated events. In this expert-led discussion, Drs. Ravi Kalhan and Meilan Han break down the latest GOLD updates, explain how to use eosinophil counts to guide treatment, and discuss when to consider adding biologic therapy. Dr. Kalhan is the Louis A. Simpson Professor of Pulmonary Medicine and Director of the Asthma and COPD Program at Northwestern Medicine in Chicago. Dr. Han is a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan Health in Ann Arbor. This episode of Deep Breaths: Updates from CHEST was supported by a non-promotional, non-CME educational program brought to you by CHEST in collaboration with and sponsored by GSK.
Keywords
- chronic obstructive pulmonary disease
- eosinophil counts
- long-term control
Sponsors
GSK
More episodes of Deep Breaths: Updates from CHEST
- What Type 2 Inflammation in COPD Means for Treatment Decision Making
- Recognizing Methamphetamine-Associated PAH: Strategies for Complex Care
- Redefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy
- Clinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment
- Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
- Targeting IL-5 in Severe Asthma: The Role of Biologic Therapies
Explore listener stats, chart rankings, contacts and more on the Deep Breaths: Updates from CHEST podcast page.